Abstract
Asthma and Chronic Obstructive Pulmonary Disease (COPD) have a high prevalence in society, and their pathophysiology are associated with increased pulmonary inflammation, which also occurs in the overlapping of Asthma and COPD (ACO). Furthermore, melatonin showed modulatory activity in inflammation and oxidative stress. Therefore, melatonin is a possible therapeutic target in the treatmen…